Evaluating the toxicity and therapeutic potential of ibogaine in the treatment of chronic opioid abuse

Expert Opin Drug Metab Toxicol. 2021 Sep;17(9):1019-1022. doi: 10.1080/17425255.2021.1944099. Epub 2021 Jun 24.
No abstract available

Keywords: Adverse event; cytochrome p450 2d6; hERG channel; hallucinogen; noribogaine; opioid use disorder; opioid withdrawal; qt prolongation.

Publication types

  • Editorial

MeSH terms

  • Animals
  • Hallucinogens / adverse effects
  • Hallucinogens / pharmacology
  • Hallucinogens / therapeutic use*
  • Humans
  • Ibogaine / adverse effects
  • Ibogaine / pharmacology
  • Ibogaine / therapeutic use*
  • Opioid-Related Disorders / drug therapy*

Substances

  • Hallucinogens
  • Ibogaine